Cambridge-based vaccine developer Variation Biotechnologies Inc. has raised a combined $7.8 million in a pair of debt financings, according to federal documents filed yesterday.
Variation Biotech Taps Backers for $7.8M in Debt Funding
July 19, 2011 | Media Mentions